Table 1.
Demographic data for patients with CD, UC, and the HC group
| HC (n=98) | CD (n=49) | p-valuea | UC (n=56) | p-valueb | |
|---|---|---|---|---|---|
| Age | 38±10 | 38±11 | 0.803 | 40±11 | 0.301 |
| Sex (female/male), n | 51/47 | 24/25 | 0.726 | 22/34 | 0.12 |
| Disease duration (months) | – | 39.41±46.83 | 54.79±49.58 | ||
| BMI (kg/m2) | 26.34±3.64 | 24.76±6.25 | 0.116 | 25.28±5.57 | 0.16 |
| Glucose (mg/dL) | 90.83±9.55 | 95.10±16.31 | 0.096 | 95.70±10.42 | 0.004 |
| Smoking, n (%) | 0.050 | 0.003 | |||
| No | 62 (63.3) | 24 (49.0) | 34 (60.7) | ||
| Yes | 30 (30.6) | 16 (32.7) | 9 (16.1) | ||
| Ex-smoker | 6 (6.1) | 9 (18.4) | 13 (23.2) | ||
| Cholesterol (mg/dL) | 188.89±36.22 | 170.71±39.7 | 0.007 | 183.02±47.43 | 0.398 |
| HDL (mg/dL) | 49.27±12.49 | 51.24±17.31 | 0.436 | 53.59±26.26 | 0.259 |
| LDL (mg/dL) | 115.80±32.46 | 97.80±33.24 | 0.002 | 107.62±40.0 | 0.182 |
| Current treatment, n (%) | |||||
| Mesalamine | 38 (77) | 56 (100) | |||
| Azathioprine | 39 (80) | 18 (32) | |||
| Anti-TNF | 13 (20) | 0 |
Notes: All values are represented as mean ± standard deviation, unless stated otherwise.
a
p-value between CD group and HC and
b
p-value between UC group and HC. Bold represents statistically significant values.
Abbreviations: CD, Crohn’s disease; UC, ulcerative colitis; HC, healthy control; BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TNF, tumor necrosis factor.